LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (drug combination treatments). Dataset 1 of 2: Cell count and normalized growth rate inhibition values. - Dataset (ID:20259)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol 1 Concentration | Small Mol 1 Conc Unit | Small Molecule 2 | Small Mol 2 Concentration | Small Mol 2 Conc Unit | Biological Replicate | Technical Replicate | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Alpelisib | 1.1111 | uM | Lapatinib | 5.7735 | uM | 2 | 1 | 1843 | 1722 | 5129 | -0.0453 |
| BT-20 | Dactolisib | 0.0412 | uM | Lapatinib | 5.7735 | uM | 2 | 2 | 1843 | 2595 | 5278 | 0.2526 |
| BT-20 | Alpelisib | 0.2138 | uM | Lapatinib | 5.7735 | uM | 2 | 3 | 1843 | 3328 | 5162 | 0.4882 |
| BT-20 | Alpelisib | 1.1111 | uM | Lapatinib | 5.7735 | uM | 1 | 3 | 2751 | 1802 | 4650 | -0.4280 |
| BT-20 | Dactolisib | 0.0047 | uM | Lapatinib | 5.7735 | uM | 1 | 3 | 2751 | 4957 | 4650 | 1.1757 |